Private Equity
Sonic Corp. named Jeffrey Schutz to its board. The Oklahoma City-based chain of drive-in restaurants said Schutz is managing director of Centennial Ventures. Leonard Lieberman also retired as a director after 21 years at Sonic. Centennial Ventures is a Denver-based VC firm with about $500 million of assets under management.
2 min read · 31 August 2010
SVB Financial Group (Nasdaq: SIVB) promoted Greg Becker to president. The holding company said Becker will remain president of Silicon Valley Bank , a position he has held since 2008. Ken Wilcox will remain chief executive officer of SVB Financial Group and Silicon Valley Bank.
4 min read · 31 August 2010
ClearCount Medical Solutions closes its $5 million in Series B financing round. The Pittsburgh, Pa.-based company will use the funds to drive market penetration as well as R&D of its RFID-based solutions for hospital patient safety applications. The round was supported by new and existing investors, including Draper Triangle Ventures and Draper Fisher Jurvetson.
3 min read · 31 August 2010
Austin Ventures and Bob Carter, who is the co-founder of National Financial Partners, formed a life insurance distribution company. Austin Ventures invested $5 million and committed another $45 million in support of the newly created business that will provide exclusive ownership opportunities for the nation's leading independent insurance producers.
3 min read · 31 August 2010
4 min read · 31 August 2010
3 min read · 30 August 2010
3 min read · 30 August 2010
3 min read · 30 August 2010
Glu Mobile Inc. received gross proceeds of about $13.5 million from a completed private placement. Existing shareholders that joined in the financing include Greenway Capital, Cannell Capital, Cypress Capital, Granite Global Ventures, New Enterprise Associates, Scale Venture Partners and Stephens Investment Management. Glu Mobile is a San Mateo, Calif.-based publisher of mobile games.
2 min read · 30 August 2010
San Diego, Calif.-based Otonomy Inc. raised $38.5 million via a Series B financing. The round was co-led by Novo Ventures and RiverVest Venture Partners, and joined by Domain Associates and TPG Biotech. The clinical-stage biopharmaceutical concern previously raised around $10 million in Series A funding with Avalon Ventures in June 2010. Avalon participated in the latest round.
3 min read · 30 August 2010